CAR-Like T Cells Enhance Tumor Response in Gastroesophageal Cancer

(MedPage Today) — SAN FRANCISCO — The response rate in metastatic gastroesophageal cancer improved by a relative 50% when patients received experimental activated T cells in addition to standard therapy, according to a small phase II study…